Ajanta Pharma Limited (AJANTPHARM) — Announcement | 2 July 2026
Ajanta Pharma announced that its Paithan manufacturing facility in Maharashtra received a Voluntary Action Indicated classification from the US FDA following a cGMP inspection conducted between 13-21 April 2026. The company previously disclosed the inspection on 22 April 2026. The FDA report confirms compliance with current Good Manufacturing Practices standards for the site.
About Ajanta Pharma Limited (AJANTPHARM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when AJANTPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AJANTPHARM — Free💡 Ask AI about this filing
📊 More AJANTPHARM filings
- 🔴 Corporate Action — 30 July 2026 Ajanta Pharma announced that August 5, 2026 will be the record date for determining shareholders eli...
- 🔴 Corporate Action — 30 July 2026 Ajanta Pharma announced a 1st interim dividend of Rs. 32 per share (Rs. 400 cr. total) for FY27, pay...
- 🟡 Board Meeting — 30 July 2026 Ajanta Pharma announced its Q1 FY2027 results on 30 July 2026, reporting 25% revenue growth to Rs 1,...
- Announcement — 30 July 2026 Ajanta Pharma announced that its Nomination and Remuneration Committee allotted 23,400 equity shares...
- 🔴 Financial Results — 21 July 2026 Ajanta Pharma announced a revised timing for its Q1 FY2027 earnings conference call, now scheduled f...
🔥 Also filed on 2 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AJANTPHARM files new disclosures
Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AJANTPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research